Peer-reviewedCC BY-NC-NDJCEM case reports
Discontinuation of palopegteriparatide in chronic hypoparathyroidism without rebound hypocalcemia
Related
- Prediction of early postoperative hypocalcemia and hypoparathyroidism after thyroidectomy for papillary thyroid carcinoma: dual-outcome prediction models
- Partial attenuated PTH suppression of calcimimetics may be due to the resulting hypocalcemia or a significant decrease in serum calcium levels within the normal reference range without adequate calcium supplementation
- Practice patterns for chronic hypoparathyroidism: data from patients and physicians in France
- Reversible heart failure and subsequent bradyarrhythmia during long-term follow-up in a patient with chronic hypocalcemia: a case report
- Impact of renin-angiotensin system inhibitors discontinuation in advanced chronic kidney disease: a target trial emulation
BibTeX
@article{anon2026discontinuation,
title = {{Discontinuation of palopegteriparatide in chronic hypoparathyroidism without rebound hypocalcemia}},
journal = {JCEM case reports},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13659921},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Discontinuation of palopegteriparatide in chronic hypoparathyroidism without rebound hypocalcemia
PY - 2026
DA - 2026/10/13
JO - JCEM case reports
UR - https://europepmc.org/article/PMC/PMC13659921
SN - 2755-1520
ER -